MEDICA B Overview
Médica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico.
Price History & Performance
|Historical stock prices|
|Current Share Price||Mex$45.20|
|52 Week High||Mex$25.50|
|52 Week Low||Mex$45.80|
|1 Month Change||2.84%|
|3 Month Change||42.18%|
|1 Year Change||73.51%|
|3 Year Change||41.25%|
|5 Year Change||5.36%|
|Change since IPO||904.44%|
Recent News & Updates
Investors Shouldn't Overlook Médica Sur. de's (BMV:MEDICAB) Impressive Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
|MEDICA B||MX Healthcare||MX Market|
Return vs Industry: MEDICA B exceeded the MX Healthcare industry which returned -15.8% over the past year.
Return vs Market: MEDICA B exceeded the MX Market which returned 32.5% over the past year.
|MEDICA B volatility|
|MEDICA B Beta||0.36|
Stable Share Price: MEDICA B is more volatile than 90% of MX stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: MEDICA B's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of MX stocks.
About the Company
Médica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. The company offers bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast cosmetic, stereotactic radio, hip arthroplasty, knee arthroscopy, shoulder arthroscopy, spine, lithiasis, radical prostatectomy, and prostate surgeries. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services.
Médica Sur. de Fundamentals Summary
|MEDICA B fundamental statistics|
Is MEDICA B overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MEDICA B income statement (TTM)|
|Cost of Revenue||Mex$3.42b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||8.07|
|Net Profit Margin||16.94%|
How did MEDICA B perform over the long term?See historical performance and comparison
3.3%Current Dividend Yield
Is Médica Sur. de undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MEDICA B (MX$45.2) is trading below our estimate of fair value (MX$594.36)
Significantly Below Fair Value: MEDICA B is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: MEDICA B is good value based on its PE Ratio (5.6x) compared to the South American Healthcare industry average (16.5x).
PE vs Market: MEDICA B is good value based on its PE Ratio (5.6x) compared to the MX market (12.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MEDICA B's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MEDICA B is good value based on its PB Ratio (1.2x) compared to the XS Healthcare industry average (2.9x).
How is Médica Sur. de forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Médica Sur. de has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Médica Sur. de performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MEDICA B has high quality earnings.
Growing Profit Margin: MEDICA B's current net profit margins (16.9%) are higher than last year (8%).
Past Earnings Growth Analysis
Earnings Trend: MEDICA B's earnings have grown significantly by 39.4% per year over the past 5 years.
Accelerating Growth: MEDICA B's earnings growth over the past year (212%) exceeds its 5-year average (39.4% per year).
Earnings vs Industry: MEDICA B earnings growth over the past year (212%) exceeded the Healthcare industry 103.4%.
Return on Equity
High ROE: MEDICA B's Return on Equity (21.6%) is considered high.
How is Médica Sur. de's financial position?
Financial Position Analysis
Short Term Liabilities: MEDICA B's short term assets (MX$2.4B) exceed its short term liabilities (MX$1.3B).
Long Term Liabilities: MEDICA B's short term assets (MX$2.4B) exceed its long term liabilities (MX$1.2B).
Debt to Equity History and Analysis
Debt Level: MEDICA B's debt to equity ratio (21.9%) is considered satisfactory.
Reducing Debt: MEDICA B's debt to equity ratio has increased from 0.4% to 21.9% over the past 5 years.
Debt Coverage: MEDICA B's debt is well covered by operating cash flow (172.5%).
Interest Coverage: MEDICA B's interest payments on its debt are well covered by EBIT (17.9x coverage).
What is Médica Sur. de current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: MEDICA B's dividend (3.32%) is higher than the bottom 25% of dividend payers in the MX market (1.88%).
High Dividend: MEDICA B's dividend (3.32%) is low compared to the top 25% of dividend payers in the MX market (5%).
Stability and Growth of Payments
Stable Dividend: MEDICA B's dividend payments have been volatile in the past 10 years.
Growing Dividend: MEDICA B's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (16.4%), MEDICA B's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Dr. Misael Uribe Esquivel serves as Chairman and Chief Executive Officer at Médica Sur, SAB de CV and served as its Executive President.
Experienced Board: MEDICA B's board of directors are seasoned and experienced ( 10.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Médica Sur, S.A.B. de C.V.'s employee growth, exchange listings and data sources
- Name: Médica Sur, S.A.B. de C.V.
- Ticker: MEDICA B
- Exchange: BMV
- Founded: 1966
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: Mex$5.481b
- Shares outstanding: 121.27m
- Website: https://www.medicasur.com.mx
Number of Employees
- Médica Sur, S.A.B. de C.V.
- Puente de Piedra 150
- Toriello Guerra, Tlalpan
- Mexico City
- Distrito Federal
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/27 22:16|
|End of Day Share Price||2021/10/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.